DD219672A5 - Verfahren zur herstellung von basensalzen von piroxicam, abgeschieden auf einem pharmazeutisch annehmbaren traeger - Google Patents

Verfahren zur herstellung von basensalzen von piroxicam, abgeschieden auf einem pharmazeutisch annehmbaren traeger Download PDF

Info

Publication number
DD219672A5
DD219672A5 DD84262259A DD26225984A DD219672A5 DD 219672 A5 DD219672 A5 DD 219672A5 DD 84262259 A DD84262259 A DD 84262259A DD 26225984 A DD26225984 A DD 26225984A DD 219672 A5 DD219672 A5 DD 219672A5
Authority
DD
German Democratic Republic
Prior art keywords
piroxicam
solvent
carrier
mixture
sodium
Prior art date
Application number
DD84262259A
Other languages
German (de)
English (en)
Inventor
Melvin M K Noseworthy
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD219672A5 publication Critical patent/DD219672A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
    • C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Stabilization Of Oscillater, Synchronisation, Frequency Synthesizers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
DD84262259A 1983-04-25 1984-04-24 Verfahren zur herstellung von basensalzen von piroxicam, abgeschieden auf einem pharmazeutisch annehmbaren traeger DD219672A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48830383A 1983-04-25 1983-04-25

Publications (1)

Publication Number Publication Date
DD219672A5 true DD219672A5 (de) 1985-03-13

Family

ID=23939186

Family Applications (1)

Application Number Title Priority Date Filing Date
DD84262259A DD219672A5 (de) 1983-04-25 1984-04-24 Verfahren zur herstellung von basensalzen von piroxicam, abgeschieden auf einem pharmazeutisch annehmbaren traeger

Country Status (28)

Country Link
EP (1) EP0123520B1 (sv)
JP (1) JPS59205375A (sv)
KR (1) KR840008345A (sv)
AT (1) ATE36531T1 (sv)
AU (1) AU548451B2 (sv)
BG (1) BG40810A3 (sv)
CA (1) CA1213220A (sv)
CS (1) CS246078B2 (sv)
DD (1) DD219672A5 (sv)
DE (1) DE3473454D1 (sv)
DK (1) DK165168C (sv)
EG (1) EG17887A (sv)
ES (1) ES531866A0 (sv)
FI (1) FI82377C (sv)
GR (1) GR81938B (sv)
GT (1) GT198404085A (sv)
HU (1) HU194217B (sv)
IE (1) IE57327B1 (sv)
IL (1) IL71598A (sv)
MX (1) MX159889A (sv)
NO (1) NO165177C (sv)
NZ (1) NZ207930A (sv)
PH (1) PH18864A (sv)
PL (1) PL144064B1 (sv)
PT (1) PT78473B (sv)
RO (1) RO88420A (sv)
YU (1) YU44232B (sv)
ZA (1) ZA843013B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582831A (en) * 1984-11-16 1986-04-15 Pfizer Inc. Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
HU200926B (en) * 1988-10-28 1990-09-28 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules
GB9212450D0 (en) * 1992-06-11 1992-07-22 Indena Spa New derivatives of non-steroidal anti-inflammatory,analgesic and/or antipyretic substances,their use and pharmaceutical formulations containing them
KR100446829B1 (ko) * 2002-02-20 2004-09-04 한국유나이티드제약 주식회사 가용화된 피록시캄을 함유한 확산형 정제의 조성물 및그의 제조방법
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
JP2010083826A (ja) * 2008-10-01 2010-04-15 Nihon Generic Co Ltd オキシカム系化合物を含む固形製剤を製造する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN160683B (sv) * 1981-06-01 1987-07-25 Pfizer
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts

Also Published As

Publication number Publication date
HU194217B (en) 1988-01-28
PL247378A1 (en) 1985-03-26
DK165168C (da) 1993-03-08
YU44232B (en) 1990-04-30
NO841611L (no) 1984-10-26
IE57327B1 (en) 1992-07-29
JPH0251527B2 (sv) 1990-11-07
NO165177B (no) 1990-10-01
IE840982L (en) 1984-10-25
IL71598A (en) 1987-01-30
DK204484D0 (da) 1984-04-24
RO88420A (ro) 1986-01-30
ATE36531T1 (de) 1988-09-15
ES8505365A1 (es) 1985-05-16
JPS59205375A (ja) 1984-11-20
MX159889A (es) 1989-09-27
ZA843013B (en) 1985-12-24
FI82377C (sv) 1991-03-11
FI841604A0 (fi) 1984-04-24
PT78473A (en) 1984-05-01
NZ207930A (en) 1986-09-10
NO165177C (no) 1991-01-09
PT78473B (en) 1986-08-28
PH18864A (en) 1985-10-21
HUT34023A (en) 1985-01-28
BG40810A3 (en) 1987-02-16
IL71598A0 (en) 1984-07-31
GR81938B (sv) 1984-12-12
PL144064B1 (en) 1988-04-30
CA1213220A (en) 1986-10-28
AU548451B2 (en) 1985-12-12
EP0123520B1 (en) 1988-08-17
CS246078B2 (en) 1986-10-16
YU72484A (en) 1988-04-30
DK204484A (da) 1984-10-26
AU2716084A (en) 1984-11-01
FI82377B (fi) 1990-11-30
KR840008345A (ko) 1984-12-14
ES531866A0 (es) 1985-05-16
FI841604A (fi) 1984-10-26
DE3473454D1 (en) 1988-09-22
GT198404085A (es) 1985-10-16
DK165168B (da) 1992-10-19
EP0123520A1 (en) 1984-10-31
EG17887A (en) 1991-03-30

Similar Documents

Publication Publication Date Title
US3147187A (en) Sustained release pharmaceutical
DE69407404T2 (de) Feste zubereitung mit hoher freisetzung, ihre herstellung und verwendung
DE69110561T2 (de) Mittel zur Behandlung und Vorbeugung von Bauchentzündungen, die als Wirkstoff Zink-L-Carnosin-Salze oder -Komplexe enthalten.
AT394310B (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
DE3751860T2 (de) Verwendung von spezifischem Kernmaterial und Schichten zur Herstellung pharmazeutischer Formulierungen, die stabil gegen die Verfärbung von Omeprazol sind
DE69013296T3 (de) Einzeldosen mit verzögerter Arzneistofffreigabe.
DE69400356T2 (de) Quervernetzte amylose als bindemittel/sprengmittel fuer tabletten
EP0212537B1 (de) Verfahren zur Herstellung einer stabilen Modifikation von Torasemid sowie Arzneimittel enthaltend Torasemid
DE3437599A1 (de) Ibuprofen enthaltende weichgelatinekapseln und verfahren zu ihrer herstellung
EP0582186A1 (de) Verfahren zur Herstellung von festen Arzneiformkörpern mit protrahierter 2-Stufen-Freisetzung
DE20219293U1 (de) Pharmazeutische Pellets enthaltend Tamsulosin
DE3325615A1 (de) Medizinisches praeparat enthaltend pirprofen
DE2541658A1 (de) Verfahren zur herstellung von hohlen makroteilchen
CH640738A5 (de) Arzneimitteltablette zur peroralen applikation und verfahren zu deren herstellung.
EP1077703B1 (de) Orale arzneiformen mit reproduzierbarer wirkstofffreisetzung von gatifloxacin oder pharmazeutisch verwendbaren salzen oder hydraten
EP0176773B1 (de) Feste Arzneizubereitung enthaltend Nitrendipin und Verfahren zur ihrer Herstellung
CH637913A5 (de) Biologisch wirksame eisen(ii)-verbindung, eisenpraeparat und verfahren zur herstellung der eisen(ii)-verbindung.
DE19821625C1 (de) Pharmazeutische Zubereitung
DE69108007T2 (de) Verfahren zur herstellung einer einen wärme-, licht- und feuchtigkeit empfindlichen wirkstoff mit einer monoklinisch kristallinen struktur enthaltenden tabletten oder dragee zusammensetzung.
DE69433012T2 (de) Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
EP0591363A1 (de) Torasemid-haltige pharmazeutische zusammensetzungen
DD219672A5 (de) Verfahren zur herstellung von basensalzen von piroxicam, abgeschieden auf einem pharmazeutisch annehmbaren traeger
EP2161022B1 (de) Herstellung von Phosphatbindern und auf diese Weise hergestellte Phosphatbinder
EP0469440A1 (de) Feste orale Applikationsformen, die als Wirkstoff Ifosfamid enthalten
DE69224793T2 (de) Magnesiumhaltiges Arzneimittel mit verlängerter Wirkstoffabgabe

Legal Events

Date Code Title Description
NPV Change in the person, the name or the address of the representative (addendum to changes before extension act)
ENJ Ceased due to non-payment of renewal fee